Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling

BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Na, He, Song, Ma, Li, Ponnusamy, Murugavel, Tang, Jinhua, Tolbert, Evelyn, Bayliss, George, Zhao, Ting C., Yan, Haidong, Zhuang, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546966/
https://www.ncbi.nlm.nih.gov/pubmed/23342059
http://dx.doi.org/10.1371/journal.pone.0054001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546966/
https://www.ncbi.nlm.nih.gov/pubmed/23342059
http://dx.doi.org/10.1371/journal.pone.0054001

Ejemplares similares